Functional ACE2 deficiency leading to angiotensin imbalance in the pathophysiology of COVID-19.
Joshua R Cook,John Ausiello +1 more
Reads0
Chats0
TLDR
In this paper, a review of the available data remains incomplete but are consistent with the possibility that the broad multisystem dysfunction of COVID-19 is due in large part to functional ACE2 deficiency leading to angiotensin imbalance with consequent immune dysregulation and endothelial cell dysfunction.Abstract:
SARS-CoV-2, the virus responsible for COVID-19, uses angiotensin converting enzyme 2 (ACE2) as its primary cell-surface receptor. ACE2 is a key enzyme in the counter-regulatory pathway of the broader renin-angiotensin system (RAS) that has been implicated in a broad array of human pathology. The RAS is composed of two competing pathways that work in opposition to each other: the "conventional" arm involving angiotensin converting enzyme (ACE) generating angiotensin-2 and the more recently identified ACE2 pathway that generates angiotensin (1-7). Following the original SARS pandemic, additional studies suggested that coronaviral binding to ACE2 resulted in downregulation of the membrane-bound enzyme. Given the similarities between the two viruses, many have posited a similar process with SARS-CoV-2. Proponents of this ACE2 deficiency model argue that downregulation of ACE2 limits its enzymatic function, thereby skewing the delicate balance between the two competing arms of the RAS. In this review we critically examine this model. The available data remain incomplete but are consistent with the possibility that the broad multisystem dysfunction of COVID-19 is due in large part to functional ACE2 deficiency leading to angiotensin imbalance with consequent immune dysregulation and endothelial cell dysfunction.read more
Citations
More filters
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets.
Masoumeh Farahani,Zahra Niknam,Leila Mohammadi Amirabad,Nasrin Amiri-Dashatan,Mehdi Koushki,Mohadeseh Nemati,Fahima Danesh Pouya,Mostafa Rezaei-Tavirani,Yousef Rasmi,Lobat Tayebi +9 more
TL;DR: In this article, a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in-vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
Molecular pathways involved in COVID-19 and potential pathway-based therapeutic targets
TL;DR: In this paper , a review of the possible mechanisms of the host response following SARS-CoV-2 infection and surveyed current research conducted by in vitro, in vivo and human observations, as well as existing suggestions.
Journal ArticleDOI
Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response
Alessio Basolo,Anello Marcello Poma,Diana Bonuccelli,Agnese Proietti,Elisabetta Macerola,Clara Ugolini,Liborio Torregrossa,Riccardo Giannini,P. Vignali,Fulvio Basolo,Ferruccio Santini,Antonio Toniolo +11 more
TL;DR: In this paper , the authors detected the SARS-CoV-2 genome in the adipose tissue of 13/23 (56%) cases of the COVID-19 cohort, showing that the virus may directly infect the parenchymal cells of subcutaneous fat.
Journal ArticleDOI
Endothelial contribution to COVID-19: an update on mechanisms and therapeutic implications
TL;DR: In this paper, the authors reviewed the clinical characteristics of COVID-19 associated endothelial dysfunction and the likely pathological mechanisms underlying the disease including direct cell entry or indirect immune overreactions after SARS-CoV-2 infection.
Journal ArticleDOI
Role of the Renin-Angiotensin-Aldosterone and Kinin-Kallikrein Systems in the Cardiovascular Complications of COVID-19 and Long COVID.
Samantha Cooper,Eleanor Boyle,Sophie R. Jefferson,Calum R. A. Heslop,Pirathini Mohan,Gearry G. J. Mohanraj,Hamza A. Sidow,Rory C. P. Tan,Stephen J. Hill,Jeanette Woolard +9 more
TL;DR: In this article, the authors reviewed the impact of COVID-19 on the cardiovascular system, the mechanisms by which dysregulation of the RAAS and KKS can occur following virus infection and the future implications for pharmacological therapies.
References
More filters
Journal ArticleDOI
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
TL;DR: It is shown that renin expression and plasma angiotensin II production were increased severalfold in vitamin D receptor-null (VDR-null) mice, leading to hypertension, cardiac hypertrophy, and increased water intake, and 1,25(OH)(2)D(3) is a novel negative endocrine regulator of the renin-angiotens in system.
Journal ArticleDOI
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Michael A. Crackower,Renu Sarao,Renu Sarao,Gavin Y. Oudit,Gavin Y. Oudit,Chana Yagil,Ivona Kozieradzki,Ivona Kozieradzki,Sam E. Scanga,Antonio J. Oliveira-dos-Santos,Joan da Costa,Liyong Zhang,York Pei,James W. Scholey,Carlos M. Ferrario,Armen S. Manoukian,Mark C. Chappell,Peter H. Backx,Peter H. Backx,Yoram Yagil,Josef M. Penninger +20 more
TL;DR: These genetic data for ACE2 show that it is an essential regulator of heart function in vivo and targeted disruption of ACE2 in mice results in a severe cardiac contractility defect, increased angiotensin II levels, and upregulation of hypoxia-induced genes in the heart.
Journal ArticleDOI
Physiology of local renin-angiotensin systems.
TL;DR: A large body of data is now available to support the existence of numerous organ-based RAS exerting diverse physiological effects, and universal paracrine and autocrine actions may be important in many organ systems and can mediate important physiological stimuli.
Journal ArticleDOI
Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury.
Yingxia Liu,Yang Yang,Cong Zhang,Cong Zhang,Fengming Huang,Fuxiang Wang,Jing Yuan,Zhaoqin Wang,Jinxiu Li,Jianming Li,Cheng Feng,Zheng Zhang,Lifei Wang,Ling Peng,Li Chen,Yuhao Qin,Dandan Zhao,Shuguang Tan,Lu Yin,Jun Xu,Cong-Zhao Zhou,Chengyu Jiang,Lei Liu +22 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics, as well as potential biomarkers for predicting disease severity in 2019-nCoV-infected patients in Shenzhen, China, suggest a number of potential diagnosis biomarkers and angiotensin receptor blocker drugs for potential repurposing treatment of 2019- nCoV infection.
Journal ArticleDOI
Cytokine Storm.
David C. Fajgenbaum,Carl H. June +1 more
TL;DR: From the Department of Medicine, Division of Translational Medicine and Human Genetics, Center for Cytokine Storm Treatment and Laboratory, and the Center for Cellular Immunotherapies and the Parker Institute for Cancer Immunotherapy, University of Pennsylvania, Philadelphia.